PMC:7252096 / 20006-20238 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13798","span":{"begin":4,"end":9},"obj":"Body_part"},{"id":"T19523","span":{"begin":22,"end":33},"obj":"Body_part"},{"id":"T40933","span":{"begin":51,"end":62},"obj":"Body_part"},{"id":"T71611","span":{"begin":124,"end":129},"obj":"Body_part"},{"id":"T53856","span":{"begin":165,"end":170},"obj":"Body_part"},{"id":"T6586","span":{"begin":174,"end":180},"obj":"Body_part"},{"id":"T46157","span":{"begin":217,"end":221},"obj":"Body_part"},{"id":"T54100","span":{"begin":227,"end":231},"obj":"Body_part"}],"attributes":[{"id":"A50036","pred":"fma_id","subj":"T13798","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A29831","pred":"fma_id","subj":"T19523","obj":"http://purl.org/sig/ont/fma/fma62499"},{"id":"A66676","pred":"fma_id","subj":"T40933","obj":"http://purl.org/sig/ont/fma/fma62499"},{"id":"A77642","pred":"fma_id","subj":"T71611","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A15965","pred":"fma_id","subj":"T53856","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A33641","pred":"fma_id","subj":"T6586","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A99757","pred":"fma_id","subj":"T46157","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A6153","pred":"fma_id","subj":"T54100","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"lub cells, 10% type I pneumocytes, and 22% type II pneumocytes. Data generated using Seq-Well S3 (Table S3).\n(B). Number of cells (left) and % (right) ACE2+TMPRSS2+ cells by tissue source (granuloma versus uninvolved lung) and cell "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T38","span":{"begin":174,"end":180},"obj":"Body_part"},{"id":"T39","span":{"begin":217,"end":221},"obj":"Body_part"}],"attributes":[{"id":"A38","pred":"uberon_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"A39","pred":"uberon_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"lub cells, 10% type I pneumocytes, and 22% type II pneumocytes. Data generated using Seq-Well S3 (Table S3).\n(B). Number of cells (left) and % (right) ACE2+TMPRSS2+ cells by tissue source (granuloma versus uninvolved lung) and cell "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T69593","span":{"begin":4,"end":9},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T27809","span":{"begin":39,"end":41},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T85798","span":{"begin":110,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T80701","span":{"begin":124,"end":129},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T46135","span":{"begin":165,"end":170},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T9290","span":{"begin":217,"end":221},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T95835","span":{"begin":217,"end":221},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"lub cells, 10% type I pneumocytes, and 22% type II pneumocytes. Data generated using Seq-Well S3 (Table S3).\n(B). Number of cells (left) and % (right) ACE2+TMPRSS2+ cells by tissue source (granuloma versus uninvolved lung) and cell "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T77","span":{"begin":48,"end":50},"obj":"Chemical"},{"id":"T78","span":{"begin":94,"end":96},"obj":"Chemical"},{"id":"T79","span":{"begin":104,"end":106},"obj":"Chemical"}],"attributes":[{"id":"A77","pred":"chebi_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_29388"},{"id":"A79","pred":"chebi_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/CHEBI_29388"}],"text":"lub cells, 10% type I pneumocytes, and 22% type II pneumocytes. Data generated using Seq-Well S3 (Table S3).\n(B). Number of cells (left) and % (right) ACE2+TMPRSS2+ cells by tissue source (granuloma versus uninvolved lung) and cell "}

{"project":"LitCovid-sentences","denotations":[{"id":"T114","span":{"begin":64,"end":108},"obj":"Sentence"},{"id":"T115","span":{"begin":109,"end":113},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"lub cells, 10% type I pneumocytes, and 22% type II pneumocytes. Data generated using Seq-Well S3 (Table S3).\n(B). Number of cells (left) and % (right) ACE2+TMPRSS2+ cells by tissue source (granuloma versus uninvolved lung) and cell "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":189,"end":198},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0032252"}],"text":"lub cells, 10% type I pneumocytes, and 22% type II pneumocytes. Data generated using Seq-Well S3 (Table S3).\n(B). Number of cells (left) and % (right) ACE2+TMPRSS2+ cells by tissue source (granuloma versus uninvolved lung) and cell "}

{"project":"LitCovid-PubTator","denotations":[{"id":"562","span":{"begin":151,"end":155},"obj":"Gene"},{"id":"563","span":{"begin":156,"end":163},"obj":"Gene"},{"id":"564","span":{"begin":189,"end":198},"obj":"Disease"}],"attributes":[{"id":"A562","pred":"tao:has_database_id","subj":"562","obj":"Gene:59272"},{"id":"A563","pred":"tao:has_database_id","subj":"563","obj":"Gene:7113"},{"id":"A564","pred":"tao:has_database_id","subj":"564","obj":"MESH:D006099"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lub cells, 10% type I pneumocytes, and 22% type II pneumocytes. Data generated using Seq-Well S3 (Table S3).\n(B). Number of cells (left) and % (right) ACE2+TMPRSS2+ cells by tissue source (granuloma versus uninvolved lung) and cell "}